Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Mar 11, 2016, after the close
10-K filed Mar 11, 2016, 71 days after period end · 0001299130-16-000186
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Revenue | $36.28M | $16.90M | $9.13M | $5.88M |
| Net Income | -$1.41M | -$18.98M | -$17.23M | -$21.67M |
| EPS Diluted | -$0.02 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| — |
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
